PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota, USA.\', \'Department of Quality, Experience, and Affordability, Mayo Clinic, Rochester, Minnesota, USA.\', \'Division of Health Care Delivery Research, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA.\', \'Division of Gastroenterology, Mayo Clinic, Rochester, Minnesota, USA.\', \'Division of Preventive, Occupational Medicine, and Aerospace Medicine, Mayo Clinic, Rochester, Minnesota, USA.\', \'Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1093/cid/ciab229
?:hasPublicationType
?:journal
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
is ?:pmid of
?:pmid
?:pmid
  • 33704435
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Impact of the Coronavirus Disease 2019 (COVID-19) Vaccine on Asymptomatic Infection Among Patients Undergoing Preprocedural COVID-19 Molecular Screening.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all